What is the debt of Zai Lab this year?
Zai Lab has a debt level of -790.15 USD this year.
Zai Lab Debt 2024
Zai Lab Debt
-790.15 USD
Ticker
9688.HK
ISIN
KYG9887T1085
WKN
A2DX7H
In 2024, Zai Lab's total debt was -790.15 USD, a -21.65% change from the -1,008.47 USD total debt recorded in the previous year.
Zai Lab Aktienanalyse
What does Zai Lab do?
Zai Lab Ltd is a biotech company based in Shanghai, China, that focuses on the development and commercialization of innovative drugs and therapies for unmet medical needs. The company's history dates back to 2014 when Dr. Samantha Du, an experienced pharma executive, founded the company to realize her vision of a modern, science-based biotech company in China. Zai Lab's business model is based on several strategic pillars. On one hand, the company collaborates with leading pharma and biotech research centers to discover, develop, and market new active ingredients and therapies. On the other hand, Zai Lab also promotes the acquisition of promising companies and technologies to strengthen its innovative power and expand its product portfolio. Another important aspect of Zai Lab's business model is its close collaboration with the Chinese government and healthcare system to simplify and improve access to new drugs and therapies for patients in China. Zai Lab operates in various business areas and markets to cover a wide range of medical needs. One of Zai Lab's main areas is oncology pharmaceuticals used to treat cancer. The company has focused primarily on novel active ingredients that have the potential to selectively target certain types of cancer cells while sparing healthy cells. Zai Lab's key oncology products include Niraparib, a PARP inhibitor for the treatment of ovarian cancer, and ZL-2301, a SHRPI inhibitor for the treatment of liver and lung cancer. Another important business area for Zai Lab is immunology and autoimmunity. Here, the company develops new therapies and medications that can modulate and regulate the immune system in certain disease conditions. One of the most promising products is the drug FOLFIRINOX, an immunomodulator for the treatment of chronic inflammatory bowel diseases. In addition to oncology and immunology, Zai Lab is also involved in other areas of medicine such as gastroenterology, infectious diseases, and neuroscience. In these fields, the company develops new antibiotics, vaccines, and medications for the treatment of diseases such as hepatitis B, Lyme disease, and Alzheimer's. Overall, Zai Lab aims to improve the health and well-being of patients in China and worldwide through its broad product range and innovation power. In recent years, Zai Lab has written an impressive growth story. The company has raised several million dollars in investments since its inception and has built a strong network and collaboration with other companies. Recently, Zai Lab has also attracted additional investors through IPOs in Hong Kong and New York, further strengthening its position as a leading biotech company in China. Overall, Zai Lab is an emerging biotech company that aims to fulfill medical needs in China and worldwide with its broad range of products and services and its innovation power. The company relies on close collaboration with leading research centers, companies, and government agencies, and strives to improve the health and well-being of patients worldwide. Zai Lab ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Zai Lab's Debt Structure
Zai Lab's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Zai Lab's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Zai Lab’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Zai Lab’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Zai Lab stock
What was the debt of Zai Lab compared to the previous year?
The debt of Zai Lab has increased by -21.65% compared to the previous year dropped.
What are the consequences of high debt for investors in Zai Lab?
High debt can pose a risk for investors of Zai Lab, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Zai Lab?
Low debt means that Zai Lab has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Zai Lab affect the company?
An increase in debt of Zai Lab can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Zai Lab affect the company?
A reduction in debt of Zai Lab can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Zai Lab?
Some factors that can influence the debt of Zai Lab include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Zai Lab so important for investors?
The debts of Zai Lab are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Zai Lab take to change the debt?
To change the debt, Zai Lab can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Zai Lab pay?
Over the past 12 months, Zai Lab paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zai Lab is expected to pay a dividend of 0 USD.
What is the dividend yield of Zai Lab?
The current dividend yield of Zai Lab is .
When does Zai Lab pay dividends?
Zai Lab pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zai Lab?
Zai Lab paid dividends every year for the past 0 years.
What is the dividend of Zai Lab?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Zai Lab located?
Zai Lab is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zai Lab kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zai Lab from 9/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.
When did Zai Lab pay the last dividend?
The last dividend was paid out on 9/30/2024.
What was the dividend of Zai Lab in the year 2023?
In the year 2023, Zai Lab distributed 0 USD as dividends.
In which currency does Zai Lab pay out the dividend?
The dividends of Zai Lab are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zai Lab
Our stock analysis for Zai Lab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zai Lab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
